D Medical Industries Ltd. (TASE:DMDC) portfolio company Nilimedix Ltd. today announced that Nilimedix has signed an exclusive distribution agreement for its insulin pumps in Mexico.

Both parties are now seeking approval of the agreement by the Mexican regulatory authorities and this process should take several months.

According to data from the International Diabetes Federation, 6,826,000 Mexicans suffer from diabetes and this figure will rise to 12 million by 2030.

The share of D Medical, which owns 93% of Nilimedix, rose 5.9% in early afternoon trading on the TASE to NIS 0.18.

Published by Globes [online], Israel business news - www.globes-online.com - on January 26, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010